Evidence map›Paper›PMID 30654517›Full record

ArticleInternational journal of molecular sciences2019

Additives for Efficient Biodegradable Antifouling Paints.

Fabienne Faÿ, Maëlle Gouessan, Isabelle Linossier, Karine Réhel

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Polymeric Systems as Antimicrobial or Antifouling Agents.International journal of molecular sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Fabienne FaÿUniversité Bretagne Sud, EA 3884, LBCM, IUEM, F-56100 Lorient, France. fabienne.fay@univ-ubs.fr.ORCID 0000-0001-7887-4849
Maëlle GouessanUniversité Bretagne Sud, EA 3884, LBCM, IUEM, F-56100 Lorient, France. maelle.gouessan@univ-ubs.fr.
Isabelle LinossierUniversité Bretagne Sud, EA 3884, LBCM, IUEM, F-56100 Lorient, France. isabelle.linossier@univ-ubs.fr.
Karine RéhelUniversité Bretagne Sud, EA 3884, LBCM, IUEM, F-56100 Lorient, France. karine.rehel@univ-ubs.fr.
Université de Bretagne Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The evolution of regulations concerning biocidal products aims to increase protection of the environment (e.g., EU Regulation No 528/2012) and requires the development of new non-toxic anti-fouling (AF) systems. The development of these formulations implies the use of ingredients (polymers, active substances, additives) that are devoid of toxicity towards marine environments. In this context, the use of erodable antifouling paints based on biodegradable polymer and authorized biocides responds to this problem. However, the efficiency of paints could be improved by the use of specific additives. For this purpose, three additives acting as surface modifiers were studied (Tween 80, Span 85 and PEG-silane). Their effects on parameters involved in antifouling efficiency as hydrophobicity, hydration and copper release were studied. Results showed that the addition of 3% of additives modulated hydrophobicity and hydration without an increase of copper release and significantly reduced microfouling development. Efficient paints based on biodegradable polymer and with no organic biocide could be obtained by mixing copper thiocyanate and additives.

Indexed as

BiofoulingAnti-Bacterial AgentsBacteriaBiodegradation, EnvironmentalBiofilmsBiomassCopperHydrophobic and Hydrophilic InteractionsMicroalgaeMicrobial Sensitivity TestsPaintWaterAnti-Bacterial AgentsCopperWateradditivesantifoulingbiofilmcopper paint

Identifiers

PMID30654517
PMCPMC6358926
OpenAlexW2909291009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.